-
Posted by
Two Blokes Tue at 12:30 PM -
Filed in
Stock
-
1 view
AstraZeneca (AZN) said Tuesday it's planning to invest $50 billion in expanding its manufacturing and research presence in the U.S. by 2030, as worries about President Donald Trump's tariffs loom over the industry.
